A Scalable System for Production of Functional Pancreatic Progenitors from Human Embryonic Stem Cells

Development of a human embryonic stem cell (hESC)-based therapy for type 1 diabetes will require the translation of proof-of-principle concepts into a scalable, controlled, and regulated cell manufacturing process. We have previously demonstrated that hESC can be directed to differentiate into pancr...

Descripción completa

Detalles Bibliográficos
Autores principales: Schulz, Thomas C., Young, Holly Y., Agulnick, Alan D., Babin, M. Josephine, Baetge, Emmanuel E., Bang, Anne G., Bhoumik, Anindita, Cepa, Igor, Cesario, Rosemary M., Haakmeester, Carl, Kadoya, Kuniko, Kelly, Jonathan R., Kerr, Justin, Martinson, Laura A., McLean, Amanda B., Moorman, Mark A., Payne, Janice K., Richardson, Mike, Ross, Kelly G., Sherrer, Eric S., Song, Xuehong, Wilson, Alistair Z., Brandon, Eugene P., Green, Chad E., Kroon, Evert J., Kelly, Olivia G., D’Amour, Kevin A., Robins, Allan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356395/
https://www.ncbi.nlm.nih.gov/pubmed/22623968
http://dx.doi.org/10.1371/journal.pone.0037004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3356395/
https://www.ncbi.nlm.nih.gov/pubmed/22623968
http://dx.doi.org/10.1371/journal.pone.0037004

Ejemplares similares